Developer docs
API playgroundTry for free, no card

Search company profiles

GenieRX

Full company profile

uuid022q7vz

Namestring
GenieRX
Legal namestring
GenieMD, Inc.
Websiteurl
genierx.com.
Company typeenum
Private
Founded yearstring
-
Descriptiontext

GenieRX (legally GenieMD, Inc.) is a US-based telehealth company headquartered in Danville that operates a HIPAA-compliant unified virtual care platform connecting individual patients with physicians for prescription treatments covering lifestyle and wellness conditions. The platform enables online consultations and prescription medication fulfillment for hair loss, weight loss (including GLP-1 medications), erectile dysfunction, testosterone therapy, STD/STI/warts, dry eye, scars, and foot health. Its core technology is an integrated workflow that combines virtual doctor consultations with direct medication fulfillment, and it carries HIPAA and Legitscript certifications as baseline regulatory trust signals.

Short descriptiontext

GenieRX (GenieMD, Inc.) is a US-based telehealth company operating a HIPAA-compliant virtual care platform that connects individual patients with physicians for lifestyle prescriptions including weight loss, ED, hair loss, and testosterone therapy, and is acquiring CVS's Omnicare for $250M.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersDanville, United States
HQ citystring
Danville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
telehealth consultations, virtual care platform, lifestyle medications, online doctor visits, prescription fulfillment
Industry2 codes
1Prescription-Based Digital Clinics (Condition-Specific Rx Programs)
CodeHLALAAADPrimaryYes
2Virtual Pharmacy & Medication Management Integration Platforms
CodeHLALABALPrimaryNo
NAICS code2 codes
  • Offices of Physicians6211
  • Services for the Elderly and Persons with Disabilities62412
SIC code2 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Telehealth and Virtual Care Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Telehealth Consultations
TypeSubscription Recurring
Description

Revenue generated from virtual doctor consultations for lifestyle medications including hair loss, weight loss, erectile dysfunction, testosterone therapy, and other conditions

genierx.com
2Medication Sales
TypeTransaction Fee
Description

Revenue from fulfillment of prescription medications for treated conditions including GLP-1 weight loss medications, ED treatments, hair loss treatments, testosterone therapy, and other lifestyle medications

genierx.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

GenieRX operates a HIPAA-compliant, Legitscript-certified virtual care platform that enables patients to consult with doctors online and receive prescription medications for lifestyle and wellness conditions including weight loss (GLP-1), erectile dysfunction, hair loss, testosterone therapy, STD/STI treatment, dry eye, scars, and foot health. The unified platform combines telehealth consultations with direct medication fulfillment and refill services for adult consumers seeking convenient access to lifestyle healthcare.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

GenieRX operates as a unified virtual care platform under the GenieMD brand, offering patients online access to doctors and prescription medications for various lifestyle and health conditions. The platform provides a comprehensive suite of services including weight loss treatments (GLP-1), erectile dysfunction medications, hair loss treatments, testosterone therapy, STD/STI/Warts treatment, dry eye care, scar management, and foot health solutions. The company also facilitates medication refills through its platform.

Product and service2 records
1GenieMD Unified Virtual Care Platform
Categorycore product
2Lifestyle Medications
Categoryservice category
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-01
Description

GenieRx Holdings LLC entered into an asset purchase agreement with CVS Health as the stalking horse bidder to acquire Omnicare, CVS Health's long-term care pharmacy subsidiary. The deal valued at approximately $250 million is subject to court approval and is expected to close in 2026. This represents a significant strategic expansion for GenieRx into the long-term care pharmacy market.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

DTC telehealth platform specializing in ED medications via subscription model. Direct competitor to GenieRX's ED vertical with similar consult-plus-fulfillment mechanics.

TypeBroad incumbent
Description

Largest publicly-traded telehealth incumbent offering virtual care across many conditions. Broad incumbent competing across GenieRX's condition categories with a wider portfolio.

TypeDirect peer
Description

Largest publicly-traded DTC telehealth platform offering prescription treatments for hair loss, ED, weight loss (GLP-1), and other lifestyle conditions. Closest direct competitor to GenieRX across nearly every category on GenieRX's platform.

4Ro
TypeDirect peer
Description

DTC telehealth company providing online consultations and prescriptions for ED, weight loss, hair loss, and fertility. Direct competitor to GenieRX with overlapping condition-specific Rx model and integrated pharmacy fulfillment.

TypeEmerging player
Description

DTC telehealth marketplace connecting patients to providers for cash-pay visits and prescriptions. Emerging competitor overlapping with GenieRX's direct-pay lifestyle care model.

TypeDirect peer
Description

Multi-brand DTC virtual care operator (Keeps for hair loss, Cove for migraine, etc.) offering condition-specific prescriptions. Closely comparable to GenieRX's multi-condition Rx platform approach.

TypeDirect peer
Description

Telehealth platform offering online doctor consultations and prescription delivery across multiple lifestyle and chronic conditions. Comparable DTC virtual care model to GenieRX.

TypeEmerging player
Description

DTC telehealth brand focused on hair loss treatment for men. Now part of Thirty Madison, but directly competes with GenieRX in the hair loss Rx category.

TypeBroad incumbent
Description

Leading long-term care pharmacy provider serving skilled nursing and senior living facilities. Highly relevant as a peer for the institutional pharmacy operations GenieRX is acquiring via Omnicare.

TypeEmerging player
Description

Weight management company that has expanded into GLP-1-supported telehealth weight loss. Direct overlap with GenieRX's weight loss vertical and adjacent to its GLP-1 Rx offering.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

GenieRX

Telehealth and Virtual Care Servicesgenierx.com.

GenieRX (GenieMD, Inc.) is a US-based telehealth company operating a HIPAA-compliant virtual care platform that connects individual patients with physicians for lifestyle prescriptions including weight loss, ED, hair loss, and testosterone therapy, and is acquiring CVS's Omnicare for $250M.

What GenieRX does

GenieRX (legally GenieMD, Inc.) is a US-based telehealth company headquartered in Danville that operates a HIPAA-compliant unified virtual care platform connecting individual patients with physicians for prescription treatments covering lifestyle and wellness conditions. The platform enables online consultations and prescription medication fulfillment for hair loss, weight loss (including GLP-1 medications), erectile dysfunction, testosterone therapy, STD/STI/warts, dry eye, scars, and foot health. Its core technology is an integrated workflow that combines virtual doctor consultations with direct medication fulfillment, and it carries HIPAA and Legitscript certifications as baseline regulatory trust signals.

GenieRX firmographics

Firmographics
Name
GenieRX
Legal name
GenieMD, Inc.
Website
https://genierx.com.
Company type
Private
Operating status
Operating
Short description
GenieRX (GenieMD, Inc.) is a US-based telehealth company operating a HIPAA-compliant virtual care platform that connects individual patients with physicians for lifestyle prescriptions including weight loss, ED, hair loss, and testosterone therapy, and is acquiring CVS's Omnicare for $250M.
Ownership category
akta.pro rank

GenieRX industry classification

Industry
Product category
Telehealth and Virtual Care Services
NAICS
Offices of Physicians (6211), Services for the Elderly and Persons with Disabilities (62412)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro primary industry
Prescription-Based Digital Clinics (Condition-Specific Rx Programs) (HLALAAAD)
akta.pro secondary industry
Virtual Pharmacy & Medication Management Integration Platforms (HLALABAL)

Keywords

  • Telehealth consultations
  • Virtual care platform
  • Lifestyle medications
  • Online doctor visits
  • Prescription fulfillment

Where GenieRX is headquartered

Location

Headquarters

HQ city
Danville
HQ country
United States
HQ region
North America

Markets served

GenieRX business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain

Revenue model

  1. Telehealth Consultations: Revenue generated from virtual doctor consultations for lifestyle medications including hair loss, weight loss, erectile dysfunction, testosterone therapy, and other conditions
  2. Medication Sales: Revenue from fulfillment of prescription medications for treated conditions including GLP-1 weight loss medications, ED treatments, hair loss treatments, testosterone therapy, and other lifestyle medications

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

GenieRX product offering

Product offering

Core offering

GenieRX operates a HIPAA-compliant, Legitscript-certified virtual care platform that enables patients to consult with doctors online and receive prescription medications for lifestyle and wellness conditions including weight loss (GLP-1), erectile dysfunction, hair loss, testosterone therapy, STD/STI treatment, dry eye, scars, and foot health. The unified platform combines telehealth consultations with direct medication fulfillment and refill services for adult consumers seeking convenient access to lifestyle healthcare.

Product overview

GenieRX operates as a unified virtual care platform under the GenieMD brand, offering patients online access to doctors and prescription medications for various lifestyle and health conditions. The platform provides a comprehensive suite of services including weight loss treatments (GLP-1), erectile dysfunction medications, hair loss treatments, testosterone therapy, STD/STI/Warts treatment, dry eye care, scar management, and foot health solutions. The company also facilitates medication refills through its platform.

Differentiator

Problem solved

Functional benefit

Products and services

  • GenieMD Unified Virtual Care Platform
  • Lifestyle Medications

Companies that use GenieRX

Customer profile

Segments1 record

Ideal customer profiles1 record

GenieRX technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

GenieRX partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • CVS Health (Omnicare)coreStrategic or Co-development Partner · 1 April 2026GenieRx Holdings LLC entered into an asset purchase agreement with CVS Health as the stalking horse bidder to acquire Omnicare, CVS Health's long-term care pharmacy subsidiary. The deal valued at approximately $250 million is subject to court approval and is expected to close in 2026. This represents a significant strategic expansion for GenieRx into the long-term care pharmacy market.

Scale indicators2 records

Recent moves4 records

Expansion highlights4 records

GenieRX competitors and assessment

Company assessment

Direct peers

  • BlueChew: DTC telehealth platform specializing in ED medications via subscription model. Direct competitor to GenieRX's ED vertical with similar consult-plus-fulfillment mechanics.
  • Hims & Hers Health: Largest publicly-traded DTC telehealth platform offering prescription treatments for hair loss, ED, weight loss (GLP-1), and other lifestyle conditions. Closest direct competitor to GenieRX across nearly every category on GenieRX's platform.
  • Ro: DTC telehealth company providing online consultations and prescriptions for ED, weight loss, hair loss, and fertility. Direct competitor to GenieRX with overlapping condition-specific Rx model and integrated pharmacy fulfillment.
  • Thirty Madison: Multi-brand DTC virtual care operator (Keeps for hair loss, Cove for migraine, etc.) offering condition-specific prescriptions. Closely comparable to GenieRX's multi-condition Rx platform approach.
  • Lemonaid Health: Telehealth platform offering online doctor consultations and prescription delivery across multiple lifestyle and chronic conditions. Comparable DTC virtual care model to GenieRX.

Broad incumbents

  • Teladoc Health: Largest publicly-traded telehealth incumbent offering virtual care across many conditions. Broad incumbent competing across GenieRX's condition categories with a wider portfolio.
  • PharMerica: Leading long-term care pharmacy provider serving skilled nursing and senior living facilities. Highly relevant as a peer for the institutional pharmacy operations GenieRX is acquiring via Omnicare.

Emerging players

  • Sesame: DTC telehealth marketplace connecting patients to providers for cash-pay visits and prescriptions. Emerging competitor overlapping with GenieRX's direct-pay lifestyle care model.
  • Keeps: DTC telehealth brand focused on hair loss treatment for men. Now part of Thirty Madison, but directly competes with GenieRX in the hair loss Rx category.
  • WeightWatchers (WW International): Weight management company that has expanded into GLP-1-supported telehealth weight loss. Direct overlap with GenieRX's weight loss vertical and adjacent to its GLP-1 Rx offering.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat2 records

Key risks6 records

Key highlights6 records

Customer concentration

GenieRX social profiles

Digital presence

GenieRX compliance and trust

Trust signal

Compliance2 records

GenieRX financial estimates

Financial estimate

Revenue estimate

Valuation estimate

GenieRX leadership team

Management profile

Number of profiles

Profiles2 records

GenieRX funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

GenieRX M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GenieRX

What does GenieRX do?

GenieRX operates a HIPAA-compliant, Legitscript-certified virtual care platform that enables patients to consult with doctors online and receive prescription medications for lifestyle and wellness conditions including weight loss (GLP-1), erectile dysfunction, hair loss, testosterone therapy, STD/STI treatment, dry eye, scars, and foot health. The unified platform combines telehealth consultations with direct medication fulfillment and refill services for adult consumers seeking convenient access to lifestyle healthcare.

Is GenieRX a public or private company?

GenieRX is a private company. It is classified as venture growth investor backed and is currently operating.

When was GenieRX founded?

GenieRX was founded in -1.

Where is GenieRX based?

GenieRX is headquartered in Danville, United States, in the North America region.

How does GenieRX make money?

Two revenue lines are on record. Telehealth Consultations are the primary driver. The others are medication Sales.

Who are GenieRX's main competitors?

Direct peers on record are BlueChew, Hims & Hers Health, Ro, Thirty Madison and Lemonaid Health. Broad incumbents are Teladoc Health and PharMerica. Emerging players are Sesame, Keeps and WeightWatchers (WW International).

Does GenieRX have an API?

No public API is recorded for GenieRX.

What industry is GenieRX in?

GenieRX's product category is Telehealth and Virtual Care Services. Its primary akta.pro industry code is HLALAAAD, Prescription-Based Digital Clinics (Condition-Specific Rx Programs), with a secondary code of HLALABAL, Virtual Pharmacy & Medication Management Integration Platforms. Its NAICS code is 6211 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ForbesCVS Sale Of Omnicare Long-Term Care Pharmacy Continues Portfolio RevampA bankruptcy court approved the sale of CVS Health's underperforming Omnicare long-term care pharmacy network to GenieRx for $250 million, with the deal expected to close later this year. GenieRx is a joint partnership between Milrose Capital LLC and Integro Healthcare Services. CVS had purchased Omnicare for over $12 billion more than a decade ago to expand into specialized drug dispensing but the business underperformed and faced fraud investigations costing the company hundreds of millions of dollars, leading CVS to divest as part of its strategy to focus on more profitable operations.FierceHealthcareCourt approves sale of CVS' Omnicare unit to GenieRx HoldingsCVS' Omnicare unit received court approval to sell to GenieRx Holdings, a joint venture of Milrose Capital and Integro Asset Management. The deal includes $250 million in cash and certain liabilities, with closure expected later this year pending regulatory approvals. Omnicare had filed for bankruptcy in September amid a $948 million fraud judgment.Investing.comOmnicare enters asset purchase deal with GenieRx as stalking horse By Investing.comOmnicare, a subsidiary of CVS Health, has entered into an asset purchase agreement with GenieRx Holdings as the stalking horse bidder in a court-supervised sale process. GenieRx is a joint partnership between Milrose Capital and Integro Asset Management, operating as Integro Healthcare Services. The agreement sets a floor price for Omnicare's assets, with a deadline of April 30, 2026 for competing bids and an auction scheduled for May 5, 2026, subject to court approval.Stock TitanOmnicare taps GenieRx as stalking horse bidderOmnicare, LLC, a subsidiary of CVS Health, has entered into an asset purchase agreement with GenieRx Holdings LLC to serve as the stalking horse bidder in its court-supervised sale process. GenieRx is a joint partnership between private investment firm Milrose Capital LLC and healthcare investment firm Integro Asset Management LLC, setting a floor price for the sale of Omnicare's assets. The deadline for competing bids is April 30, 2026, with an auction expected on May 5, 2026, subject to court approval.